Antihypertensive Drugs Market (Type - Primary, and Secondary; Therapeutic Class - Diuretics, Ace Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Other Therapeutic Classes; Distribution Channel - Retail Pharmacy, Hospital Pharmacy, and E-commerce): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : February, 2020

  • Rep Id : HC0788

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on antihypertensive drugs market provides an in-depth analysis of segments and sub-segments in the global as well as regional antihypertensive drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional antihypertensive drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global antihypertensive drugs market. According to the report, the global antihypertensive drugs market is projected to grow at a CAGR of 3.9% over the forecast period of 2019-2025.

 

Market Insight

Hypertension is a chronic condition, in which the blood pressure is elevated abnormally systolic as well as diastolic. Several conditions such as blood pressure and mental distress can take place due to hypertension. This is a major risk factor for causing cardiovascular, renal or endocrine disorders. Antihypertensive drugs are used regularly in other unrelated situations. These drugs can prevent kidney failure, acute stroke, and heart failure induced by hypertension and delay the growth of atherosclerosis by controlling the blood pressure.

 

An increase in the occurrence of hypertension across the globe is one of the major drivers for the growth of the antihypertensive drugs market. Hypertension is one of the major public health challenges in the United States as it increases the risk of cardiovascular disease. Lack of proper sleep due to irregular work shifts, lack of proper healthy and balanced diet, consumption of junk food have contributed to the increase in hypertension. In 2018, the American Heart Association (AHA) heart disease and stroke statistics update reported that about 34% of adults in the United States had hypertension. Furthermore, the rise in the aged population and sedentary lifestyle are the other key factors for the growth of the antihypertensive drugs market worldwide. The occurrence of hypertension is comparatively high in the elderly population. Almost 70% of high blood pressure patients are over 60. According to the United Nations Report, in 2017, the geriatric population is expected to rise from 962 million in 2017 to 2.1 billion by 2050. On the other side, less awareness of the antihypertensive drugs among the population is one of the main factors that may hamper the antihypertensive drugs market. Maximum people in emerging countries neglect their health-checkups and are not aware of the existing hypertension condition in them until they detect extreme symptoms. Moreover, increasing funds for research on hypertension and antihypertensive drugs is anticipated to create several growth opportunities for the antihypertensive drugs market in the next few years.

 

In terms of region, the antihypertensive drugs market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among all, North America is leading the antihypertensive drug market. This is mainly due to the easy availability of antihypertensive drugs in the region. Additionally, the increasing rate of hypertension and the growing geriatric population in the region also boosts the antihypertensive drug market. On the other hand, Asia Pacific is expected to grow at a faster rate during the forecast period. Growing awareness related to the use of antihypertensive drugs is one of the major factors for the growth of the antihypertensive drugs market. Moreover, the continuously growing life science industry boosts the growth of the market in the emerging countries in the Asia Pacific like India, China, and Malaysia.

 

Segment Covered

The report on the global antihypertensive drugs market covers segments such as type, therapeutic class, and distribution channel. On the basis of type, the sub-markets include primary, and secondary. On the basis of therapeutic class, the sub-markets include diuretics, ace inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and other therapeutic classes. On the basis of the distribution channels, the sub-markets include retail pharmacy, hospital pharmacy, and e-commerce.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Bayer AG, Merck KGaA, Boehringer Ingelheim GmbH, AstraZeneca plc, Johnson and Johnson Ltd., Pfizer, Inc., Takeda Pharmaceutical Co, Ltd.., Daiichi Sankyo Company, Sanofi S.A., and Novartis International AG.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the antihypertensive drugs market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount